---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-128022"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T03:51:41.117887+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cyclacel receives Nasdaq bid-price deficiency notice; stock at risk of delisting

## Summary
- Nasdaq notified Cyclacel on Dec 6, 2024, that common stock bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until June 4, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by June 4, 2025, Nasdaq may delist common stock; company may appeal to hearings panel.
- Cyclacel is considering alternatives including a potential reverse stock split to meet the bid-price rule.
- Common stock continues trading on Nasdaq under symbol CYCC during the grace period.

## SEC filing metadata
- accession: 0001104659-24-128022
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465924128022/0001104659-24-128022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465924128022/tm2430847d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-128022
- JSON: https://secwatch.observer/filing/0001104659-24-128022.json
- Plain text: https://secwatch.observer/filing/0001104659-24-128022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.